Clinical Trial: Effect of Remimazolam Tosylate vs Etomidate During Rapid Sequence Induction and Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration: A Two-center, Randomized, Double-Blind, Non-inferiority Trial (China)

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Remimazolam Tosylate vs Etomidate During Rapid Sequence Induction and Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration: A Two-center, Randomized, Double-Blind, Non-inferiority Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131009

Registration Time: 2026/08/27

Type: Interventional study

Primary Sponsor: Xiamen Hospital of Zhongshan Hospital affiliated to Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339221

Published by HT Digital Content Services with permission fro...